版本:
中国

BRIEF-Kempharm defers commercial program for Apadaz

Sept 15 Kempharm Inc :

* Kempharm Inc provides corporate and clinical update

* Announces intent to begin formal dispute resolution regulatory process with FDA for Apadaz

* Defers commercial program for Apadaz

* Defers commercial program for Apadaz

* Adjusts product development timelines following full pipeline analysis Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐